A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

A lot of times, ketamine leads to an unpacking of that baggage.” Krystal, who provides IV and intranasal ketamine for treatment-resistant mood disorders at the VA Connecticut Health System and ...

The nasal spray has been administered to more than 140,000 patients ... In 2023, the FDA warned of potential risks associated with ketamine treatments. “Known safety concerns associated with the use ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...

A new study finds that oral ketamine significantly reduces PTSD symptoms, with 73% of participants seeing a 50% reduction in ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.